Third Harmonic Bio, Inc. (THRD)
Jul 31, 2025 - THRD was delisted
5.38
-0.00 (-0.09%)
Inactive · Last trade price on Jul 30, 2025
Third Harmonic Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 271.61 | 285.06 | 269.07 | 288.88 | 128.28 | 8.28 |
Cash & Short-Term Investments | 271.61 | 285.06 | 269.07 | 288.88 | 128.28 | 8.28 |
Cash Growth | 3.34% | 5.94% | -6.86% | 125.19% | 1449.84% | - |
Prepaid Expenses | 4.39 | 5.48 | 3.38 | 3.96 | 0.88 | 0.16 |
Total Current Assets | 276 | 290.54 | 272.45 | 292.84 | 129.16 | 8.43 |
Property, Plant & Equipment | 2.96 | 3.17 | 3.93 | 4.36 | - | - |
Other Long-Term Assets | 0.88 | 0.9 | 1.33 | 1.48 | - | - |
Total Assets | 279.84 | 294.61 | 277.71 | 298.68 | 129.16 | 8.43 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 2.68 | 1.94 | 1.84 | 2.09 | 1.8 | 0.58 |
Accrued Expenses | 1.53 | 4.25 | 2.8 | 2.95 | 3.89 | 1.57 |
Current Portion of Leases | 0.89 | 0.86 | 0.75 | 0.39 | - | - |
Other Current Liabilities | 0.01 | 0.06 | 0.04 | 0.23 | 0 | 0.07 |
Total Current Liabilities | 5.1 | 7.11 | 5.42 | 5.65 | 5.69 | 2.21 |
Long-Term Leases | 2.11 | 2.35 | 3.21 | 3.95 | - | - |
Other Long-Term Liabilities | - | - | - | - | - | 5.88 |
Total Liabilities | 7.22 | 9.46 | 8.63 | 9.61 | 5.69 | 8.09 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 448.14 | 444.83 | 383.3 | 372.46 | 1.53 | 0.27 |
Retained Earnings | -175.52 | -159.69 | -114.22 | -83.4 | -48.24 | -18.63 |
Total Common Equity | 272.62 | 285.15 | 269.09 | 289.07 | -46.71 | -18.36 |
Shareholders' Equity | 272.62 | 285.15 | 269.09 | 289.07 | 123.48 | 0.34 |
Total Liabilities & Equity | 279.84 | 294.61 | 277.71 | 298.68 | 129.16 | 8.43 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 3 | 3.21 | 3.95 | 4.34 | - | - |
Net Cash (Debt) | 268.61 | 281.86 | 265.12 | 284.54 | 128.28 | 8.28 |
Net Cash Growth | 3.69% | 6.31% | -6.83% | 121.81% | 1449.84% | - |
Net Cash Per Share | 6.26 | 6.75 | 6.69 | 19.82 | 31.73 | 2.26 |
Filing Date Shares Outstanding | 45.13 | 45.1 | 40.71 | 40.32 | 4.24 | 3.67 |
Total Common Shares Outstanding | 44.96 | 44.86 | 40.1 | 39.38 | 4.24 | 3.67 |
Working Capital | 270.9 | 283.43 | 267.03 | 287.18 | 123.48 | 6.22 |
Book Value Per Share | 6.06 | 6.36 | 6.71 | 7.34 | -11.02 | -5.00 |
Tangible Book Value | 272.62 | 285.15 | 269.09 | 289.07 | -46.71 | -18.36 |
Tangible Book Value Per Share | 6.06 | 6.36 | 6.71 | 7.34 | -11.02 | -5.00 |
Machinery | 0.11 | 0.11 | 0.1 | 0.02 | - | - |
Construction In Progress | - | - | - | 0.02 | - | - |
Leasehold Improvements | 0.11 | 0.11 | 0.11 | - | - | - |